Journal retracts cholangiocarcinoma SNHG12 study over image integrity concerns
Frontiers in Medicine has retracted a 2021 study on the long non-coding RNA SNHG12 in intrahepatic cholangiocarcinoma after the authors ...
Frontiers in Medicine has retracted a 2021 study on the long non-coding RNA SNHG12 in intrahepatic cholangiocarcinoma after the authors ...
Bioethicist Jeremy Sugarman has outlined a seven-criterion ethical framework to guide the assessment, oversight, and conduct of basic stem cell-related ...
The journal retracted a pilot study on ketogenic diets for binge-eating disorder after an investigation found false authorship and affiliation ...
Frontiers in Medicine has retracted a 2020 mouse study on exosomal miR-25 and fracture healing after image integrity concerns and ...
Discover Medicine has retracted a 2025 case report on an esophageal hematoma in a COVID-19 ARDS patient over authorship, consent ...
BMC Neuroscience has issued an editorial expression of concern over a 2012 paper on liraglutide and lixisenatide, citing overlapping images.
A 2022 randomized trial comparing RIRS and MINI-PCNL for 20–30 mm kidney stones has been retracted over unresolved ethical approval ...
The Editors-in-Chief of Applied Biological Chemistry have retracted a 2026 rat study on fisetin and diesel particulate matter after an ...
A bibliometric analysis of 582 retracted central nervous system tumor papers found that misconduct drove over 80 percent of retractions ...
The Editor-in-Chief of Cancer Nanotechnology has retracted a 2023 paper on cetuximab-loaded egg serum albumin nanoparticles after concerns about figures ...
A Cancer Imaging correspondence flags misreported study design, unsupported validation claims and reversed responder numbers in a study of early ...
BMC Women's Health has retracted a 2023 Bayesian study of cervical cancer patient survival at the University of Gondar referral ...
A conceptual governance analysis in Frontiers in Genetics argues that generative AI operating within publishing's incentive structure risks contaminating the ...
Frontiers in Oncology has retracted a 2024 paper on sorafenib combined with tarexib for unresectable hepatocellular carcinoma after the authors ...
Frontiers in Oncology has retracted a 2025 corrigendum on the anticancer effects of ABTL0812 in glioblastoma models after the authors ...
A PNAS audit of 500,000 science, engineering, and computing papers finds fabricated references in every field examined, with the affected ...
Frontiers in Cellular Neuroscience has retracted a 2020 rat study claiming the grape pomace extract Taurisolo protects the brain from ...
A new PLOS Computational Biology perspective sets out ten practical rules defining where AI assistance in computational biology is legitimate ...
Editors at BMC Complementary Medicine and Therapies have retracted a 2021 study on fucoidan's antitumor effects in lung cancer cells ...
BMC Cancer editors have retracted a 2022 study claiming lycorine blocks tumor blood supply by docking to PDGFRα, citing overlapping ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.